Easy Pharma Exit and COC Exam Prep

💊MCQ on CLINICAL PHARMACOLOGY 1. Pharmacovigilance means: (a) Monitoring of drug safety (b) Monitoring of unethical trade of drugs (c) Monitoring pharma students (d) Monitoring drug efficacy 2. True about orphan drug is: (a) Developed for orphans (b) Drugs used very rarely (c) Drugs used for rare diseases (d) Rare drug for common diseases 3. True statement about phase 2 clinical trials is: (a) Large number of healthy volunteers are studied (b) Used to determine maximum tolerated dose (c) Used to determine efficacy (d) Used to determine toxicity 4. Good clinical practice (GCP) is not required in: (a) Preclinical phase (b) Phase I trial (c) Phase II studies (d) Phase IV studies 5. In which of the following phases of clinical trials, healthy normal human volunteers participate: (a) Phase-I (b) Phase-II (c) Phase-III (d) Phase-IV 6. There are some undesirable but unavoidable pharmacodynamic effects of a drug, which are known as: (a) Toxic effects (b) Idiosyncrasy (c) Side effects (d) Intolerance 7. The aim of post-marketing studies is: (a) Efficacy of the drug (b) Dosage of the drug (c) Deals with alteration of the drug includes absortion, distribution, binding/storage (d) To know rare adverse effects of the drug 8. In which phase of clinical trials, post-marketing surveillance of a drug is carried out: (a) Phase I (b) Phase II (c) Phase III (d) Phase IV 9. Phase 4 clinical trial also called as: (a) Human pharmacology and safety (b) Post marketing surveillance (c) Therapeutic exploration and dose ranging (d) Therapeutic confirmation 10. Phase 4 of clinical trials collect information specially about: (a) Drug efficacy (b) Drug potency (c) Drug toxicity (d) Pharmacokinetics of the drug 11. Phase 4 clinical trial is carried out: (a) Before the marketing approval of a drug (b) After a drug is marketed (c) For drugs used in rare diseases (d) For drugs used in pediatric patients